21 April, 2014 AsiaNews.it Twitter AsiaNews.it Facebook            

Help AsiaNews | About us | P.I.M.E. | | RssNewsletter





mediazioni e arbitrati, risoluzione alternativa delle controversie e servizi di mediazione e arbitrato
e-mail this to a friend printable version


» 12/04/2007 15:35
JAPAN
Kyoto University scientists break stem cell safety barriers
by Pino Cazzaniga
Dr Shinya Yamanaka’s research team eliminates the risks of cell mutation and the danger of tumors. Now it is working on finding a safe artificial genetic factor.

Tokyo (AsiaNews) – At Kyoto University the Institute for Frontier Medical Science team under Shinya Yamanaka, which found a way to convert human cells to embryo-like stem cells, is now working on eliminating the risk of tumors.

Dr Yamanaka’s first breakthrough, which AsiaNews  announced on November 23, showed how stem cells could be produced without using embryos, thus eliminating any ethical problems. The technique consists in re-programming human adult cells by inserting four genetic factors which a play a role in embryo development.

Many scientists have welcomed the discovery as a great breakthrough because it opens the way to the development of therapies based on replacing worn-out tissues with new ones.

However, we are still a long way from any therapeutic application of this discovery. Dr Yamanaka himself urges prudence.

“From about 50,000 transfected human cells, we obtained approximately 10 iPS cell clones,” he said. Indeed, he is conscious that it will take time before therapies can be developed based on the use of stem calls. And stem cell safety issues will have to be addressed since undesirable mutations like tumors can be caused.

Yamanaka and his team have moved however on a fast track. Last Friday US medical journal Nature Biotechnology reported that the Kyoto University group was able to re-program human skin cells and create induced Pluripotent Stem cells (iPS cells) without using c-Myc, the oncogene that can cause cancer.

This was not achieved in the ten days, that is between announcement of the team’s first and second breakthrough. Over a period of a hundred days (crucial in tumor development) they developed iPS cells with only three genetic factors, without inserting the c-Myc. Unlike mice that received the four genetic factors, none of those tested without c-Myc died from cancer. However, the iPS cells generated this way were less powerful that those created with the c-Myc. The next step for the research team is to find an artificial genetic factor that can take the place of the c-Myc.

Beyond the science it is important to highlight the ethical import of the Kyoto University team’s research programme.

It is well-known that embryonic stem cell research is easier and quicker because there is no need to rejuvenate cells since they are by definition embryonic. But in the case of human embryos such a solution implies not only manipulating something that is ethically inviolable but also killing the heart of those who accept it. It is much better and smarter as well as ethically acceptable to rejuvenate old cells. In the first case, there is death; in the second, regeneration.

It is also a consolation to find that the path chosen and tenaciously held by Yamanaka’s team is increasingly accepted in biotech institutions around the world, Italy included.

Carlo Alberto Redi, scientific director of the Fondazione Irccs-San Matteo in Pavia, stressed that “it is worth remembering that in 2001 that the Dulbecco Commission report, ordered by then Health Minister Umberto Veronesi, indicated that this was the way to go, insisting on the importance of funding genetic stem cell re-programming to avoid using embryos. As always in Italy funding remains a problem but this is a promising area of research.”


e-mail this to a friend printable version

See also
11/19/2004 UNITED NATIONS - VATICAN
Human cloning, science's dominion over life
by Lorenzo Fazzini
11/23/2007 JAPAN
Sacrifice of human embryos no longer “necessary”
by Pino Cazzaniga
12/18/2007 KOREA
The false “cloning pioneer” wants to work on stem cells again
11/29/2006 SOUTH KOREA
"Cloning pioneer" want to manipulate human cells again
by Theresa Kim Hwa-young
01/12/2005 SOUTH KOREA
S Korea approves cloning research

Editor's choices
ITALY - ASIA
Easter, victory over death and impotence
by Bernardo Cervellera
SYRIA
I will miss you Fr Frans, you inspired us all, says Syrian Jesuit
by Tony Homsy*A young priest from the Society of Jesus remembers the life and work of Fr Frans van der Lugt, who was killed in Homs after he refused to abandon residents beleaguered by hunger and war. "He gave and continues to give everything for the Church, Syria, and peace. His story and qualities made him an exceptional missionary and witness to the Gospel." Reprinted courtesy of 'The Jesuit Post'.
FRANCE - IRAQ
Chaldean Patriarch on the uncertain future of eastern Christians, a bridge between the West and Islam
by Mar Louis Raphael I SakoThe wars in Iraq, Libya and Afghanistan have made things worse for their peoples, especially minorities. As Western policies have been a failure, fundamentalism has grown with the Arab Spring losing out to extremism. Muslim authorities have a role in protecting rights and religious freedom. The presence of Christians in the Middle East is crucial for Muslims.

Dossier
by Giulio Aleni / (a cura di) Gianni Criveller
pp. 176
by Lazzarotto Angelo S.
pp. 528
by Bernardo Cervellera
pp. 240
Copyright © 2003 AsiaNews C.F. 00889190153 All rights reserved. Content on this site is made available for personal, non-commercial use only. You may not reproduce, republish, sell or otherwise distribute the content or any modified or altered versions of it without the express written permission of the editor. Photos on AsiaNews.it are largely taken from the internet and thus considered to be in the public domain. Anyone contrary to their publication need only contact the editorial office which will immediately proceed to remove the photos.